Mejares, Rhea Mae .

HRN: 22-41-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2026
CEFUROXIME 750MG (VIAL)
02/14/2026
02/20/2026
IV
375mg
Q8H
UTI; T/C Dengue Shock Syndrome
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: